Potential Correlation Between Heart Rate Variability With Cardiovascular Risk at Different Stages of Metabolic Syndrome
NCT06305195 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 155
Last updated 2024-03-12
Summary
The study aims to assess the beat-to-beat Heart rate variability (HRV) in different stages of metabolic diseases, including pre-diabetic and diabetic patients, compared to non-diabetic individuals.
Heart rate variability will be compared for some antidiabetic drugs used in different stages of metabolic diseases and correlated to different metabolic and inflammatory mediators.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
heart rate variability test
First, the patient is required to lie on their back to have a 5-minute continuous ECG recorded, without performing any maneuvers. Following this, deep breath test, Valsalva and stand test are performed.
Sponsors & Collaborators
-
Alexandria University
lead OTHER
Principal Investigators
-
Labiba K. El-Khordagui, Prof. Dr. · Alexandria University
-
Ahmed F. El-Yazbi, Prof. Dr. · Alamein International University and Alexandria University
-
Mohamed I. Sanhoury, Ass. prof. · Alexandria University
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-08-23
- Primary Completion
- 2024-09-01
- Completion
- 2026-10-21
Countries
- Egypt
Study Locations
More Related Trials
-
Comparison of Blood Pressure Medications on Metabolism
NCT00642434 ·Status: COMPLETED ·Phase: PHASE4
-
Arrhythmias, Microalbuminuria and Corticosteroids
NCT03453931 ·Status: COMPLETED
-
Ivabradine in Patients With Congestive Heart Failure
NCT04448899 ·Status: COMPLETED ·Phase: PHASE4
-
Examining Genetic Influence on Response to Beta-Blocker Medications in People With Type 2 Diabetes
NCT00925119 ·Status: TERMINATED ·Phase: PHASE4
-
The Effect of Norepinephrine on Cardiac Output in Patients Undergoing Liver Transplant .
NCT04376281 ·Status: COMPLETED ·Phase: NA
-
Safety Study to Lower the Risk of Heart Failure is Also Effective in Reducing Stiffness of the Arteries
NCT00829296 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
To Compare Blood and Urine Concentrations of Mirabegron (YM178) in Healthy Poor or Extensive Metabolizers for CYP2D6 and to Assess the Effect of Mirabegron on the Metabolism of Metoprolol
NCT01478490 ·Status: COMPLETED ·Phase: PHASE1
-
Glycemic Control Of Carvedilol Versus Metoprolol In Patients With Type II Diabetes Mellitus And Hypertension
NCT00060918 ·Status: COMPLETED ·Phase: PHASE4
-
Race, Natriuretic Peptides and Physiological Perturbations
NCT03070184 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase Ⅲ Study of Extended-Release Carvedilol Sulfate for the Treatment of Hypertension
NCT01970059 ·Status: UNKNOWN ·Phase: PHASE3
-
Cardiac Metabolic Modulator Treatment for Improvement of Diastolic Function in Patients With Coronary Heart Disease
NCT03887013 ·Status: UNKNOWN ·Phase: PHASE4
-
Effects of Heart Rate Reduction on Central Arterial Pressure in Healthy Individuals
NCT00825123 ·Status: TERMINATED ·Phase: PHASE4
-
Effect of Genetic Polymorphisms on Response to Beta Blocker Therapy in Egyptian Patients
NCT04900545 ·Status: COMPLETED
-
Analysis of Atropine and Propranolol Induced Changes
NCT00251602 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Ivabradine to Reduce Heart Rate Prior to Coronary CT-angiography in Advanced Heart Failure: Comparison With β-Blocker
NCT03830957 ·Status: UNKNOWN ·Phase: NA
-
Effect of Mild Therapeutic Hypothermia on the Doses of Vasopressors and Inotropes in Cardiogenic Shock Complicating Acute Myocardial Infarction
NCT06947616 ·Status: COMPLETED ·Phase: NA
-
NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals
NCT04055428 ·Status: RECRUITING ·Phase: PHASE2
-
Pathophysiology of Cardiometabolic Risk Factors in African Americans
NCT01122407 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Examine the Effect of Tesofensine and Metoprolol on the 24-hour Mean Heart Rate
NCT03488719 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Assessment of the Treatment With Cardiac Sympathetic Blockade on Chronic Heart Failure
NCT02391142 ·Status: UNKNOWN ·Phase: NA
-
The Influence of Heart Rate Reduction Upon Central Arterial Pressure in Younger and Older Healthy Individuals
NCT01029223 ·Status: WITHDRAWN ·Phase: PHASE4
-
Sympathetic Neurovascular Transduction: Role of Adrenergic Receptors and Sex Differences
NCT05997732 ·Status: RECRUITING ·Phase: PHASE4
-
A Study to Evaluate the Effects of Domperidone on Cardiac Repolarization in Healthy Volunteers
NCT01643889 ·Status: COMPLETED ·Phase: PHASE1
-
Exercise Improve Sympathetic Modulation in Chronic Heart Failure Patients
NCT02219451 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of DASH Diet and Progressive Muscle Relaxation on Cardiovascular Risks in Postmenopausal Women
NCT06600347 ·Status: RECRUITING ·Phase: NA